Table 2 Discharge diagnosis and laboratory data of individual patients with serum CXCL13 concentrations > 250 pg/ml
From: Chemokine CXCL13 in serum, CSF and blood–CSF barrier function: evidence of compartment restriction
CXCL13 (pg/ml) | Qcxcl13 | QAlb | CSF cells/µl | ||
|---|---|---|---|---|---|
CSF | Serum | ||||
Lyme neuroborreliosis | > 505 | > 505 | na | 16.5 | 80 |
Suspected primary CNS lymphoma | > 505 | > 505 | na | 99.0 | 4 |
Bacterial meningitis triggered by otitis media | 288 | > 505 | < 0.3 | 102.4 | 1275 |
Spondylodiscitis | 34 | > 505 | < 0.05 | 14.7 | 115 |
Stroke in the context of arteritis temporalis | 61 | > 505 | < 0.1 | 15.4 | 1 |
SLE with myelitis transversa | > 505 | 451 | > 1.1 | 10.2 | 31 |
Wernicke Encephalopathy and infection of unclear focus | 3 | 315 | 0.01 | 16.7 | 0 |
Lyme neuroborreliosis | > 505 | 284 | > 1.8 | 24.6 | 112 |
HSV2 meningitis | 74 | 263 | 0.3 | 8.5 | 140 |